|
시장보고서
상품코드
2054851
지질 패널 검사 시장(검사 유형별)Lipid Panel Test Market, By Test Type (Standard Lipid Profile and Advanced Lipid Testing (LDL Particle Number, Apolipoprotein B, Lipoprotein ), By Product Type, By Application, By Prescription Mode, By End User, By Geography ) |
||||||
지질 패널 검사 시장은 2026년에 127억 8,000만 달러로 추계되고 있으며, 2033년까지 220억 4,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 8.1%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 127억 8,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 8.10% | 2033년 시장 규모 예측 : | 220억 4,000만 달러 |
전 세계 지질 패널 검사 시장은 임상 진단 업계의 중요한 부문으로, 심혈관 질환의 위험을 평가하기 위해 다양한 콜레스테롤 및 중성지방 수치를 측정하는 포괄적인 혈액 검사를 포함합니다. 지질 패널 검사는 지질 프로파일 또는 리포그램이라고도 불리며, 환자의 혈액 검체내 총 콜레스테롤, 저밀도 지단백(LDL) 콜레스테롤, 고밀도 지단백(HDL) 콜레스테롤 및 중성지방 수치를 평가합니다.
이러한 진단 평가는 의료진이 동맥경화, 관상동맥 질환 및 기타 심혈관 합병증 발병 위험이 있는 개인을 선별하기 위한 기본적인 툴로 활용됩니다. 이 시장에는 효소법, 호모지니어스법, 그리고 병원, 진단 검사실, 현장 진단(POC) 환경에서 도입되고 있는 첨단 자동 분석기 등 다양한 검사 기법이 포함됩니다.
생활습관병 유병률의 증가, 고령화, 그리고 예방 의료에 대한 의식의 향상에 따라 지질 패널 검사에 대한 수요는 전 세계에서 계속 확대되고 있습니다. 고처리량 분석 장비, 휴대용 검사 기기, 디지털 헬스 플랫폼과 같은 기술적 진보가 통합됨에 따라 지질 검사 절차의 접근성과 효율성에 혁명적인 변화가 일어나, 전 세계 다양한 의료 현장에서 의료진과 환자 모두에게 더욱 편리한 환경을 제공하고 있습니다.
시장 역학
전 세계 지질 패널 검사 시장은 주로 전 세계 심혈관 질환, 당뇨병, 비만의 유병률 증가에 힘입어 성장하고 있으며, 정기적인 지질 모니터링 및 선별 검사에 대한 큰 수요를 창출하고 있습니다. 특히 선진국을 중심으로 진행되고 있는 세계적 고령화는 고령자들이 빈번한 심혈관 위험 평가와 지질 프로파일 모니터링을 필요로 하므로 시장 성장에 크게 기여하고 있습니다.
고속 자동 분석기, 현장 진단(POC) 장비 및 휴대용 지질 검사 솔루션 개발을 포함한 진단 기기의 기술적 진보는 검사의 정확성, 효율성 및 접근성을 향상시켜 시장 확장을 주도하고 있습니다. 예방 의료 조치, 심혈관 질환 선별 검사 프로그램 및 의료 인식 제고 캠페인을 추진하는 정부의 노력은 시장 수요를 더욱 촉진하고 있습니다.
그러나 시장에는 몇 가지 제약 요인도 존재합니다. 첨단 진단 장비와 검사 절차에 따른 높은 비용은 의료 자원이 제한적인 의료 현장이나 개발도상 지역에서 의료 서비스 접근성을 저해할 수 있습니다. 진단 기기의 승인, 품질관리 기준 및 검사실 인증과 관련된 엄격한 규제 요건은 시장 진입 장벽이 되며, 제조사의 규정 준수 비용을 증가시킵니다. 또한 일부 지역의 의료 인프라 부족, 숙련된 검사 전문가의 부족, 그리고 미흡한 보상 정책 역시 시장 성장을 저해하고 있습니다.
그럼에도 불구하고 의료 인프라 확충, 의료비 증가, 심혈관 건강에 대한 의식의 향상가 두드러지는 신흥 시장에는 큰 기회가 존재합니다. 인공지능, 기계 학습 알고리즘, 원격의료 플랫폼의 통합은 혁신적인 지질 검사 솔루션 및 원격 모니터링 기능 개발을 위한 기회를 제공합니다. 재택 의료 및 자가 모니터링 기기의 보급 추세는 소비자가 사용하기 편리한 지질 검사 제품의 가능성을 열어주고 있으며, 한편 진단 기기 제조사와 의료 제공자 간의 제휴는 전 세계 시장 진출과 서비스 확대를 촉진할 가능성이 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)를 바탕으로 전 세계 지질 패널 검사 시장의 주요 업체들을 분석하고 있습니다.
- 이 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 지질 패널 검사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 지질 패널 검사 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 지질 패널 검사 시장 : 테스트 유형별, 2021-2033년
제5장 세계의 지질 패널 검사 시장 : 제품 유형별, 2021-2033년
제6장 세계의 지질 패널 검사 시장 : 용도별, 2021-2033년
제7장 세계의 지질 패널 검사 시장 : 처방 형태별, 2021-2033년
제8장 세계의 지질 패널 검사 시장 : 최종사용자별, 2021-2033년
제9장 세계의 지질 패널 검사 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
KSA 26.06.18Lipid Panel Test Market is estimated to be valued at USD 12.78 Bn in 2026 and is expected to reach USD 22.04 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 12.78 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.10% | 2033 Value Projection: | USD 22.04 Bn |
The global lipid panel test market represents a critical segment of the clinical diagnostics industry, encompassing comprehensive blood tests that measure various cholesterol and triglyceride levels to assess cardiovascular disease risk. Lipid panel tests, also known as lipid profiles or lipograms, evaluate total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides in patients' blood samples.
These diagnostic assessments serve as fundamental screening tools for healthcare providers to identify individuals at risk of developing atherosclerosis, coronary artery disease, and other cardiovascular complications. The market encompasses various testing methodologies including enzymatic assays, homogeneous assays, and advanced automated analyzers deployed across hospitals, diagnostic laboratories, and point-of-care settings.
With the increasing prevalence of lifestyle-related diseases, aging populations, and growing awareness of preventive healthcare measures, the demand for lipid panel testing continues to expand globally. The integration of technological advancements such as high-throughput analyzers, portable testing devices, and digital health platforms has revolutionized the accessibility and efficiency of lipid testing procedures, making them more convenient for both healthcare providers and patients across diverse healthcare settings worldwide.
Market Dynamics
The global lipid panel test market is primarily driven by the escalating prevalence of cardiovascular diseases, diabetes, and obesity worldwide, creating substantial demand for regular lipid monitoring and screening procedures. The aging global population, particularly in developed countries, significantly contributes to market growth as elderly individuals require frequent cardiovascular risk assessments and lipid profile monitoring.
Technological advancements in diagnostic equipment, including the development of high-throughput automated analyzers, point-of-care testing devices, and portable lipid testing solutions, enhance testing accuracy, efficiency, and accessibility, thereby driving market expansion. Government initiatives promoting preventive healthcare measures, cardiovascular disease screening programs, and healthcare awareness campaigns further stimulate market demand.
However, the market faces certain restraints including high costs associated with advanced diagnostic equipment and testing procedures, which may limit accessibility in resource-constrained healthcare settings and developing regions. Stringent regulatory requirements for diagnostic device approvals, quality control standards, and laboratory certifications create barriers to market entry and increase compliance costs for manufacturers. Limited healthcare infrastructure, shortage of skilled laboratory professionals, and inadequate reimbursement policies in certain regions also hinder market growth.
Nevertheless, significant opportunities exist in emerging markets with expanding healthcare infrastructure, increasing healthcare expenditure, and growing awareness about cardiovascular health. The integration of artificial intelligence, machine learning algorithms, and telemedicine platforms presents opportunities for developing innovative lipid testing solutions and remote monitoring capabilities. The rising trend of home-based healthcare and self-monitoring devices creates potential for consumer-friendly lipid testing products, while partnerships between diagnostic companies and healthcare providers can facilitate market penetration and service expansion globally.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global lipid panel test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, SD Biosensor, Inc., PTS Diagnostics, Horiba Medical, Elitech Group, Menarini Group, VivaChek Biotech (Hangzhou) Co., Ltd., and Mico Bio Med.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global lipid panel test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lipid panel test market
Market Segmentation
- Test Type Insights (Revenue, USD Bn, 2021 - 2033)
- Standard Lipid Profile
- Total Cholesterol
- Triglycerides
- Low-Density Lipoprotein (LDL) Cholesterol
- High-Density Lipoprotein (HDL) Cholesterol
- Advanced Lipid Testing
- LDL Particle Number (LDL-P)
- Apolipoprotein B (ApoB)
- Lipoprotein(a) (Lp(a))
- Others (HDL Subclasses, VLDL Cholesterol etc.)
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Devices
- Automated Analyzers
- Point-of-Care Testing Devices
- Spectrophotometers
- Others
- Reagents and Kits
- Cholesterol Test Kits
- HDL and LDL Kits
- Triglyceride Test Kits
- Test Strips
- Other Product Types
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Hyperlipidemia
- Hypertriglyceridemia
- Familial Hypercholesterolemia
- Hypo Lipoproteinemia
- Tangier Disease
- Atherosclerosis
- Other Lipid Disorders
- Prescription Mode Insights (Revenue, USD Bn, 2021 - 2033)
- Prescription-Based Testing
- Over-the-Counter (OTC) Testing
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Pathology Laboratories
- Diagnostic Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- Academic and Research Institutes
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott Laboratories
- Beckman Coulter Inc.
- Hoffmann-La Roche Ltd.
- Randox Laboratories Ltd.
- Thermo Fisher Scientific Inc.
- Siemens Healthcare GmbH
- Bio-Rad Laboratories Inc.
- Nova Biomedical Corporation
- SD Biosensor, Inc.
- PTS Diagnostics
- Horiba Medical
- Elitech Group
- Menarini Group
- VivaChek Biotech (Hangzhou) Co., Ltd.
- Mico Bio Med
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Lipid Panel Test Market, By Test Type
- Global Lipid Panel Test Market, By Product Type
- Global Lipid Panel Test Market, By Application
- Global Lipid Panel Test Market, By Prescription Mode
- Global Lipid Panel Test Market, By End User
- Global Lipid Panel Test Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Lipid Panel Test Market, By Test Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Standard Lipid Profile
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Total Cholesterol
- Triglycerides
- Low-Density Lipoprotein (LDL) Cholesterol
- High-Density Lipoprotein (HDL) Cholesterol
- Advanced Lipid Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- LDL Particle Number (LDL-P)
- Apolipoprotein B (ApoB)
- Lipoprotein(a) (Lp(a))
- Others (HDL Subclasses, VLDL Cholesterol etc.)
5. Global Lipid Panel Test Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Automated Analyzers
- Point-of-Care Testing Devices
- Spectrophotometers
- Others
- Reagents and Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cholesterol Test Kits
- HDL and LDL Kits
- Triglyceride Test Kits
- Test Strips
- Other Product Types
6. Global Lipid Panel Test Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hyperlipidemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hypertriglyceridemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Familial Hypercholesterolemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hypo Lipoproteinemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Tangier Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Atherosclerosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Lipid Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Lipid Panel Test Market, By Prescription Mode, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Prescription-Based Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Over-the-Counter (OTC) Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Lipid Panel Test Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pathology Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Lipid Panel Test Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Beckman Coulter Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Randox Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthcare GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nova Biomedical Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SD Biosensor, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PTS Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Horiba Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elitech Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Menarini Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- VivaChek Biotech (Hangzhou) Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mico Bio Med
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
